Giulia Fabbri

6.5k total citations · 2 hit papers
43 papers, 2.6k citations indexed

About

Giulia Fabbri is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Giulia Fabbri has authored 43 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Giulia Fabbri's work include Chronic Lymphocytic Leukemia Research (7 papers), Italian Fascism and Post-war Society (5 papers) and Cancer Genomics and Diagnostics (4 papers). Giulia Fabbri is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Italian Fascism and Post-war Society (5 papers) and Cancer Genomics and Diagnostics (4 papers). Giulia Fabbri collaborates with scholars based in Italy, United States and United Kingdom. Giulia Fabbri's co-authors include Riccardo Dalla‐Favera, Laura Pasqualucci, Raúl Rabadán, Charles G. Mullighan, Gianluca Gaïdano, Davide Rossi, Amy Chadburn, Annalisa Chiarenza, Jing Ma and Adina Grunn and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Giulia Fabbri

36 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of the coding genome of diffuse large B-cell lymphoma

2011 673 citations Laura Pasqualucci, Владимир Трифонов et al. Nature Genetics profile →
Inactivating mutations of acetyltransferase genes in B-cell lymphoma

2011 644 citations Laura Pasqualucci, Annalisa Chiarenza et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giulia Fabbri Italy	17	1.4k	1.1k	831	610	605	43	2.6k
Monica Messina Italy	20	803 0.6×	1.1k 1.0×	845 1.0×	581 1.0×	393 0.6×	49	2.2k
Mara Compagno Italy	18	1.1k 0.8×	847 0.8×	553 0.7×	698 1.1×	542 0.9×	33	2.4k
Tony G. Willis United Kingdom	13	675 0.5×	890 0.8×	553 0.7×	526 0.9×	404 0.7×	17	1.8k
Sharon Barrans United Kingdom	21	506 0.4×	1.7k 1.6×	962 1.2×	1.0k 1.7×	248 0.4×	54	2.3k
Susana Ben‐Neriah Canada	22	504 0.4×	1.9k 1.8×	990 1.2×	1.3k 2.2×	279 0.5×	60	2.6k
Tongwei Mo United States	9	1.1k 0.8×	673 0.6×	490 0.6×	537 0.9×	546 0.9×	15	2.4k
Kenichi Takeshita United States	24	975 0.7×	995 0.9×	943 1.1×	821 1.3×	193 0.3×	77	2.7k
Magda Pinyol Spain	28	1.1k 0.8×	1.6k 1.5×	799 1.0×	1.3k 2.2×	325 0.5×	42	2.7k
Stefan Gesk Germany	37	1.5k 1.1×	2.5k 2.3×	1.2k 1.4×	1.4k 2.2×	660 1.1×	80	4.3k
Cristina Scielzo Italy	29	783 0.6×	1.1k 1.0×	1.7k 2.0×	558 0.9×	228 0.4×	56	2.8k

Countries citing papers authored by Giulia Fabbri

Since Specialization

Citations

This map shows the geographic impact of Giulia Fabbri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Fabbri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Fabbri more than expected).

Fields of papers citing papers by Giulia Fabbri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Fabbri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Fabbri. The network helps show where Giulia Fabbri may publish in the future.

Co-authorship network of co-authors of Giulia Fabbri

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Fabbri. A scholar is included among the top collaborators of Giulia Fabbri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Fabbri. Giulia Fabbri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

André, Fabrice, Giulia Fabbri, R. McEwen, et al.. (2025). 7O Trastuzumab deruxtecan (T-DXd) ± pertuzumab (P) in previously untreated HER2+ metastatic breast cancer (mBC): Clinical efficacy and exploratory subgroup analyses in DESTINY-Breast07. ESMO Open. 10. 104163–104163. 3 indexed citations

Xie, Mingchao, Siyu Liu, Andrew G. Chambers, et al.. (2025). Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancer. Molecular Cancer. 25(1). 6–6.

Fabbri, Giulia, et al.. (2024). Dynamics of Mucosal Integration of Machined versus Anodized Titanium Implants. Journal of Dental Research. 104(3). 270–279. 1 indexed citations

Munugalavadla, Veerendra, Aleksandra Markovets, Qin‐Wen Liu, et al.. (2023). Abstract 3369: Utility of ctDNA-based targeted methylation MRD assay for hematological malignancies. Cancer Research. 83(7_Supplement). 3369–3369. 2 indexed citations

Xie, Mingchao, Andreas Spitzmüller, Harald Hessel, et al.. (2023). 1505 Spatial profiling of the SCLC tumor microenvironment defined by high MHC-I expression reveals association with functionally relevant antigen presentation. SHILAP Revista de lepidopterología. A1669–A1669. 1 indexed citations

Fabbri, Giulia, et al.. (2023). Anthropogenic hybridization and its influence on the adaptive potential of the Sardinian wild boar (Sus scrofa meridionalis). Journal of Applied Genetics. 64(3). 521–530. 1 indexed citations

Johnson, Melissa L., Judy S. Wang, Gerald S. Falchook, et al.. (2023). Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours. British Journal of Cancer. 128(10). 1906–1915. 23 indexed citations

Fuselli, Silvia, Giulia Fabbri, Roberta Bisconti, et al.. (2022). From STRs to SNPs via ddRAD ‐seq: Geographic assignment of confiscated tortoises at reduced costs. Evolutionary Applications. 15(9). 1344–1359. 4 indexed citations

Fabbri, Giulia. (2022). Intersectional activism on social media: Anti-racist and feminist strategies in the digital space. Journal of Postcolonial Writing. 58(5). 713–728. 2 indexed citations

10.

Arslan, Shukaib, Shaun Fleming, Nitin Jain, et al.. (2022). Safety and Tolerability of AZD0466 As Monotherapy for Patients with Advanced Hematological Malignancies. Preliminary Results from an Ongoing Phase I/II Trial. Blood. 140(Supplement 1). 9091–9093.

11.

Bertrán-Alamillo, Jordi, Edmund H. Wilkes, Hilary Lewis, et al.. (2021). Abstract 1107: Precision phosphoproteomic analysis in Chr22q11.2 amplified NSCLC cells reveals distinct signaling corruption and response to Aurora kinase B inhibition. Cancer Research. 81(13_Supplement). 1107–1107.

12.

Liu, Zhaoqi, Akihide Yoshimi, Jiguang Wang, et al.. (2020). Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization. Cancer Discovery. 10(6). 806–821. 70 indexed citations

13.

Vita, Serena De, Janet L. Karlix, Carl Cook, et al.. (2019). First-in-human study of AZD5153, a small molecule inhibitor of bromodomain protein 4 (BRD4), in patients (pts) with relapsed/refractory (RR) malignant solid tumor and lymphoma: Preliminary data.. Journal of Clinical Oncology. 37(15_suppl). 3085–3085. 17 indexed citations

14.

Donà, Maria Gabriella, Francesca Rollo, Barbara Pichi, et al.. (2017). Evaluation of the Xpert® HPV assay in the detection of Human Papillomavirus in formalin-fixed paraffin-embedded oropharyngeal carcinomas. Oral Oncology. 72. 117–122. 10 indexed citations

15.

Rollo, Francesca, Alessandra Latini, Barbara Pichi, et al.. (2017). Prevalence and determinants of oral infection by Human Papillomavirus in HIV-infected and uninfected men who have sex with men. PLoS ONE. 12(9). e0184623–e0184623. 28 indexed citations

16.

Fabbri, Giulia & Riccardo Dalla‐Favera. (2016). The molecular pathogenesis of chronic lymphocytic leukaemia. Nature reviews. Cancer. 16(3). 145–162. 187 indexed citations

17.

Trimarchi, Thomas, Erhan Bilal, Panagiotis Ntziachristos, et al.. (2014). Genome-wide Mapping and Characterization of Notch-Regulated Long Noncoding RNAs in Acute Leukemia. Cell. 158(3). 593–606. 340 indexed citations

18.

Messina, Monica, Ilaria Del Giudice, Hossein Khiabanian, et al.. (2014). Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness. Blood. 123(15). 2378–2388. 54 indexed citations

19.

Pasqualucci, Laura, Владимир Трифонов, Giulia Fabbri, et al.. (2011). Analysis of the coding genome of diffuse large B-cell lymphoma. Nature Genetics. 43(9). 830–837. 673 indexed citations breakdown →

20.

Paganin, Maddalena, Marco Zecca, Giulia Fabbri, et al.. (2008). Minimal residual disease is an important predictive factor of outcome in children with relapsed ‘high-risk’ acute lymphoblastic leukemia. Leukemia. 22(12). 2193–2200. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact